论文部分内容阅读
目的:探讨针对急性脑梗塞患者应用依达拉奉联合丹参注射液治疗的临床疗效。方法:选取本院2013年10月至2014年10月收治的40例急性脑梗塞患者作为观察组,并以前一年度收治的38例急性脑梗塞患者作为对照组,对照组患者仅行常规临床治疗措施,观察组患者在此基础上应用依达拉奉联合丹参注射液。结果:观察组患者治疗后NIHSS评分为(2.2±1.0)分,临床总有效率为87.5%,均显著好于对熙组,具有统计学意义(P<0.05)。结论:依达拉奉联合丹参注射液治疗急性脑梗塞可迅速改善临床症状,促进神经功能恢复,具有较好的临床应用效果。
Objective: To investigate the clinical efficacy of edaravone combined with Salvia miltiorrhiza injection in patients with acute cerebral infarction. Methods: Forty patients with acute cerebral infarction admitted from October 2013 to October 2014 in our hospital were selected as the observation group, and 38 patients with acute cerebral infarction treated in the previous year as the control group. The patients in the control group received routine clinical treatment Measures, the observation group patients based on this application of edaravone combined Salvia injection. Results: The NIHSS score of the observation group was (2.2 ± 1.0) points after treatment, the total clinical effective rate was 87.5%, which was significantly better than that of the control group (P <0.05). Conclusion: Edaravone and Salvia miltiorrhiza injection can effectively improve the clinical symptoms and promote the recovery of neurological function in patients with acute cerebral infarction, which has a good clinical effect.